Stocksigma LogoStocksigma Logo

iSERA Lifesciences Board to Consider Q2 FY27 Results on 4th Nov'26

iSERA Lifesciences Limited announced that its Board of Directors is scheduled to meet on 4th Nov'26 to consider, approve, and take on record the standalone

iSERA Lifesciences Board to Consider Q2 FY27 Results on 4th Nov'26

iSERA Lifesciences Ltd 路 Intimation 路 04 Nov 2026, 5:30 am

iSERA Lifesciences Board to Consider Q2 FY27 Results on 4th Nov'26 iSERA Lifesciences Limited announced that its Board of Directors is scheduled to meet on 4th Nov'26 to consider, approve, and take on record the standalone un-audited financial results for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company equity shares has been closed for all designated persons from 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from iSERA Lifesciences Ltd

All iSERA Lifesciences Ltd announcements